Article info
PDFEditorial
When to think about mitochondrial disease
- Correspondence to Professor Doug M Turnbull, Wellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK; doug.turnbull{at}ncl.ac.uk
Citation
When to think about mitochondrial disease
Publication history
- Accepted April 9, 2020
- First published July 17, 2020.
Online issue publication
July 28, 2020
Article Versions
- Previous version (28 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases
- Recognition, investigation and management of mitochondrial disease
- Complex I deficiency: clinical features, biochemistry and molecular genetics
- Clinical and laboratory findings in referrals for mitochondrial DNA analysis
- Mitochondrial disease: mimics and chameleons
- Clinical mitochondrial genetics
- Uncommon mutation in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS)
- Brain imaging in mitochondrial respiratory chain deficiency: combination of brain MRI features as a useful tool for genotype/phenotype correlations
- Mitochondrial DNA polymerase γ mutations: an ever expanding molecular and clinical spectrum
- Prevalence of rare mitochondrial DNA mutations in mitochondrial disorders